Increase in PI3K signalling mimics mutated-Kras induction of pancreatic cancer

被引：3
|
作者：
Baer, R. [1 ]
Pyronnet, S. [1 ]
Guillermet-Guibert, J. [1 ]
机构：
[1] Univ Toulouse 3, CHU Rangueil, CRCT, INSERM,UMR 1037, F-31432 Toulouse, France
来源：
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY | 2013年 / 37卷 / 04期
关键词：
ADENOCARCINOMA;
D O I：
10.1016/j.clinre.2013.04.006
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：320 / 321
页数：2
相关论文
共 50 条
  • [41] Non-invasive imaging of PI3K/Akt/mTOR signalling in cancer
    Gaikwad, Snehal M.
    Ray, Pritha
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 2 (04): : 418 - 431
  • [42] Inhibition of PI3K Signalling Selectively Affects Medulloblastoma Cancer Stem Cells
    Frasson, Chiara
    Rampazzo, Elena
    Accordi, Benedetta
    Beggio, Giacomo
    Pistollato, Francesca
    Basso, Giuseppe
    Persano, Luca
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [43] Phytochemicals in cancer and their effect on the PI3K/AKT-mediated cellular signalling
    Issinger, Olaf -Georgo
    Guerra, Barbara
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 139
  • [44] SIGNALLING PI3Kδ keeps TLR4 signalling on track
    Papatriantafyllou, Maria
    NATURE REVIEWS IMMUNOLOGY, 2012, 12 (11) : 744 - 745
  • [45] Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer
    Mortazavi, Motahareh
    Moosavi, Fatemeh
    Martini, Miriam
    Giovannetti, Elisa
    Firuzi, Omidreza
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 176
  • [46] Combined MEK and PI3K Inhibition in a Mouse Model of Pancreatic Cancer
    Alagesan, Brinda
    Contino, Gianmarco
    Guimaraes, Alexander R.
    Corcoran, Ryan B.
    Deshpande, Vikram
    Wojtkiewicz, Gregory R.
    Hezel, Aram F.
    Wong, Kwok-Kin
    Loda, Massimo
    Weissleder, Ralph
    Benes, Cyril
    Engelman, Jeffrey A.
    Bardeesy, Nabeel
    CLINICAL CANCER RESEARCH, 2015, 21 (02) : 396 - 404
  • [47] Obesity and pancreatic cancer: Possible role of the PI3K/Akt pathway
    Huang, Xu-Feng
    Chen, Jiezhong
    SURGERY, 2010, 147 (04) : 596 - 596
  • [48] KRAS mutation-independent downregulation of MAPK/PI3K signaling in colorectal cancer
    Lam, Kuen Kuen
    Tang, Choong Leong
    Tan, Emile
    Wong, Siew Heng
    Cheah, Peh Yean
    MOLECULAR ONCOLOGY, 2022, 16 (05) : 1171 - 1183
  • [49] Selective Requirement of PI3K/PDK1 Signaling for Kras Oncogene-Driven Pancreatic Cell Plasticity and Cancer
    Eser, Stefan
    Reiff, Nina
    Messer, Marlena
    Seidler, Barbara
    Gottschalk, Kathleen
    Dobler, Melanie
    Hieber, Maren
    Arbeiter, Andreas
    Klein, Sabine
    Kong, Bo
    Michalski, Christoph W.
    Schlitter, Anna Melissa
    Esposito, Irene
    Kind, Alexander J.
    Rad, Lena
    Schnieke, Angelika E.
    Baccarini, Manuela
    Alessi, Dario R.
    Rad, Roland
    Schmid, Roland M.
    Schneider, Guenter
    Saur, Dieter
    CANCER CELL, 2013, 23 (03) : 406 - 420
  • [50] Targetable leukaemia dependency on noncanonical PI3Kγ signalling
    Luo, Qingyu
    Raulston, Evangeline G.
    Prado, Miguel A.
    Wu, Xiaowei
    Gritsman, Kira
    Whalen, Karley S.
    Yan, Kezhi
    Booth, Christopher A. G.
    Xu, Ran
    van Galen, Peter
    Doench, John G.
    Shimony, Shai
    Long, Henry W.
    Neuberg, Donna S.
    Paulo, Joao A.
    Lane, Andrew A.
    NATURE, 2024, 630 (8015) : 198 - 205
12345